Molecular Playground/Taxol: Difference between revisions
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' caption='Paclitaxel (also known as Taxol)' scene='Rohan_Patil/Sandbox1/Taxol/6'> | <StructureSection load='' size='350' side='right' caption='Paclitaxel (also known as Taxol)' scene='Rohan_Patil/Sandbox1/Taxol/6'> | ||
[[Image:Paclitaxel.png|frame|Paclitaxel (Taxol, Bristol-Myers Squibb)]] | [[Image:Paclitaxel.png|frame|Paclitaxel (Taxol, Bristol-Myers Squibb)]] | ||
Line 11: | Line 10: | ||
Molecular Playground Banner: "Paclitaxel (Taxol),a plant-derived natural product to treat cancer" | Molecular Playground Banner: "Paclitaxel (Taxol),a plant-derived natural product to treat cancer" | ||
< | <scene name='60/609785/Tubulin/2'>Paclitaxel binding to alpha-beta tubulin</scene> (PDB code [[1jff]]). | ||
==Production== | ==Production== | ||
Line 19: | Line 19: | ||
==Docetaxel== | ==Docetaxel== | ||
*<scene name='Molecular_Playground/Taxol/Docetaxel/4'>Docetaxel (also known as Taxotere)</scene>. | |||
Docetaxel (Taxotere, sanofi-aventis) is a semi-synthetic analog of Taxol that was discovered during the search for a more easily produced taxane anti-cancer agent. The hydroxyl group modification on docetaxel leads to an increase in the lipid solubility of the drug. It was first approved by the FDA in 1996 and is currently used in the treatment of breast, stomach and prostate cancer. Currently, Taxotere is produced from paclitaxel precursors which are extracted from ''Taxus brevifolia'', the readily available Wester Yew. | Docetaxel (Taxotere, sanofi-aventis) is a semi-synthetic analog of Taxol that was discovered during the search for a more easily produced taxane anti-cancer agent. The hydroxyl group modification on docetaxel leads to an increase in the lipid solubility of the drug. It was first approved by the FDA in 1996 and is currently used in the treatment of breast, stomach and prostate cancer. Currently, Taxotere is produced from paclitaxel precursors which are extracted from ''Taxus brevifolia'', the readily available Wester Yew. | ||